These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30191780)

  • 1. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R; Quaglia F; Klersy C; Pagella F; Ornati F; Chu F; Matti E; Spinozzi G; Plumitallo S; Grignani P; Olivieri C; Bastia R; Bellistri F; Danesino C; Benazzo M; Balduini CL
    Lancet Haematol; 2015 Nov; 2(11):e465-73. PubMed ID: 26686256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
    Halderman AA; Ryan MW; Clark C; Sindwani R; Reh DD; Poetker DM; Invernizzi R; Marple BF
    Int Forum Allergy Rhinol; 2018 Jun; 8(6):713-728. PubMed ID: 29393992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role.
    Hayama M; Maeda Y; Obata S; Tsuda T; Takeda K; Nishida T; Inohara H
    Auris Nasus Larynx; 2024 Apr; 51(2):305-312. PubMed ID: 38008660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
    Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ
    J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Penaloza A; Vekemans MC; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):616-8. PubMed ID: 21885956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal bevacizumab in the treatment of HHT -related epistaxis: a systematic review.
    Stokes P; Rimmer J
    Rhinology; 2018 Mar; 56(1):3-10. PubMed ID: 29166422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.
    Syed I; Sunkaraneni VS
    J Laryngol Otol; 2015 May; 129(5):410-5. PubMed ID: 25736077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.
    Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia.
    Hosman A; Westermann CJ; Snijder R; Disch F; Mummery CL; Mager JJ
    Rhinology; 2015 Dec; 53(4):340-4. PubMed ID: 26735132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telangiectasias, recurrent epistaxis and a strong family history-a case of Osler- Weber-Rendu Syndrome in Pakistan.
    Arif Siddiqui MM; Hafeez T; Din RU
    J Pak Med Assoc; 2024 Apr; 74(4):800-803. PubMed ID: 38751284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in epistaxis management: the experience of a dedicated hereditary haemorrhagic telangiectasia clinic.
    Anning R; Huang J; Ronan A; de Malmanche J; Asher R; Low TH
    ANZ J Surg; 2022 Mar; 92(3):499-504. PubMed ID: 34724318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
    Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.
    Begbie ME; Wallace GM; Shovlin CL
    Postgrad Med J; 2003 Jan; 79(927):18-24. PubMed ID: 12566546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review.
    Kini SD; Yiu DW; Weisberg RA; Davila JF; Chelius DC
    Ann Otol Rhinol Laryngol; 2019 May; 128(5):467-471. PubMed ID: 30693788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.